Introduction {#s1}
============

Temporomandibular (TMD) disorder refers to a set of clinical conditions involving the masticatory muscles, temporomandibular joint (TMJ) and associated structures[@r1]^)^. Pain is one of the most common and limiting clinical manifestations of this disorder[@r2],[@r3],[@r4]^)^ and can compromise quality of life[@r5], [@r6]^)^, sleep[@r7], [@r8]^)^, and psychological aspects, leading to anxiety, stress and even depression. The multifactor etiology of TMD requires a multidisciplinary team of health professionals[@r9]^)^, including a physiotherapist. A number of studies have addressed physical therapy modalities for the treatment of TMD, such as electrotherapy[@r10], [@r11]^)^, laser therapy[@r12], [@r13]^)^ and manual therapy[@r14],[@r15],[@r16]^)^.

Low-level laser therapy (LLLT) has been widely used in the health field for therapeutic purposes and biostimulation, due to its characteristics of low-intensity energy, and wavelengths capable of penetrating tissues and exerting an influence on the synthesis, release and metabolism of numerous signaling substances involved in analgesia[@r17], [@r18]^)^. Besides these neuro-pharmacological effects, there is evidence that LLLT leads to reductions in the inflammatory process, C-fiber activity, and the excitability of the nervous system, as well as an increase in blood circulation[@r19], [@r20]^)^.

The present systematic review of the literature was motivated by the wide diversity of information on LLLT in the treatment of TMDs, the variety of application parameters and the different assessment tools used in different studies. Systematic reviews are highly valued studies that provide evidence that can contribute to the establishment of guidelines and enhance the quality of clinical research[@r21]^)^. The present review was carried out to determine the different types of experimental procedures used to study the effects of LLLT in the treatment of TMD, and distinguish which studies provide evidence of the benefits of this form of therapy, as well as to identify and analyze the different assessment tools employed, to offer health professionals in this field a better understanding of the technique.

Subjects and Methods {#s2}
====================

Searches were carried out of the BIREME, MEDLINE, PubMed and SciELO electronic databases by two independent researchers for papers published in English and Portuguese during the period from 2008 to 2013. The searches began on October 1st and ended on December 20th, 2013. The search terms used were "temporomandibular joint laser therapy" and "TMJ laser treatment". An overview of the systematic review process is presented in [Fig. 1](#fig_001){ref-type="fig"}Fig. 1.Articles included in this review \*The sum of articles in each category totals more than the number of articles included in the review due to the fact that some studies reported more than one outcome..

Methods
-------

Clinical trials published between 2008 and 2013 that investigated the effect of LLLT in the treatment of TMD were included in this review. Thus, the findings of the most recent studies are presented, taking into consideration the use of LLLT in clinical practice and different evaluation methods. Each study needed to describe the type of laser, application time, administration parameters and assessment tools in order to allow the identification of the different protocols and compare the respective findings. Papers that failed to meet these criteria and reviews of the literature were excluded from the initial analysis ([Fig. 1](#fig_001){ref-type="fig"}).

The Physiotherapy Evidence Database (PEDro) scale, which is based on the Delphi list, was used to evaluate the methodological quality of the papers. Articles with higher levels of clinical evidence were selected using this scale, the reliability of which has been empirically supported. A total score of up to 10 points was attributed to each paper based on the total number of criteria met[@r22]^)^.

Two researchers who had undergone training in the use of the PEDro scale performed the reading and scoring of the papers. Neither researcher had knowledge of the scores given by the other. Agreement between the two researchers was then analyzed. In cases of disagreement, the papers were read again and the final score was determined by consensus.

A plus symbol (+) was placed on the chart for every criterion met and a minus symbol (−) was used when a criterion was not met. A question mark (?) indicated the non-scoring of a criterion due to a lack of certainty regarding whether the criterion was met. The final score was determined by summing the number of criteria met, excluding the first criterion, which is not considered in the scoring process. Papers with a final score of 4 or more points were placed in tables with descriptions of their respective variables analyzed and outcomes.

RESULTS {#s3}
=======

After the search of BIREME, MEDLINE, PubMed and SciELO electronic databases and the application of the eligibility criteria, 11 studies were selected for analysis ([Tables 1](#tbl_001){ref-type="table"}Table 1.Phototherapy parameters in randomized controlled clinical trialsAuthor/year of\
publicationNo of\
subjectsSex and\
ageType of laser and\
manufacturerEnergy density (ED)Power density (PD)Application\
timeApplication\
sitesFrequency and\
number of sessionsVenezian et al.[@r31]^)^485 men/43 women\
age 18--60\
(mean 41.58)AsGaAl/Twin laser -- MM\
Optics/780 nm25 J/cm² and 60 J/cm² of dose50 mW and\
60 mW20 and 40 sMuscles: 3 points on\
masseter and 1 point\
on temporal8 sessions; 2x/week\
for 4 weeksShirani et al.[@r34]^)^1612 women/4 men,\
age 16--37 years\
(mean 23.8)InGaAlP/AZOR- 2K/660 nm and\
AsGa/AZOR-2K/890 nm6.2 J/cm² and 1 J/cm²17.3 mW and\
9.8 mW360 s; 600 sTrigger points of\
masticatory muscles6 sessions: 2x/week\
for 3 weeksEmshoff et al.[@r35]^)^52Age 18--58 years\
(mean 42.9)HeNe/Helbo Medizintechnik/\
632.8 nm1.5 J/cm²30 mw120 sApprox. 1 cm in front\
of joint20 sessions: 2 to 3x/\
weeks for 8 weeksCarvalho et al.[@r36]^)^7415 men/59 women,\
age 46.3 ± 14.6 years? /Biowave, Kondortech/660 nm\
+ ? /Twin Flex, MM Optics/780 nm,\
790 nm or 830 nm1 to 2 J/cm² 14.2±6.8 J/cm² mean dose per session 8 J/cm^2^)30/40 mW; 40/50 mwIndicated by equipment based on ED and PD.4 points near TMJ12 sessions: 2x/weeks for 6 weeksSalmos-Brito et al.[@r37]^)^588 men/50 women, age 19--86 yearsAsGa (Thera Laser, DMC) 830 nm40 mW60 s5 points around painful TMJ and condyle12 sessions: 2x/weeks for 6 weeksMarini et al.[@r41]^)^9974 women/ 25 men, age 15--50 yearsAsGa (LUMIX 2 HFPL Fisioline) 910 nm, pulse time \< 200 ns and 50 kHz?400 mW (mean power)3 steps: 20 kHz for 10 min; 18 kHz for 5 min; 16 kWz for 5minIn right and left TMJ10 consecutive days (5 d/wk)Da Cunha LA et al.[@r38]^)^4039 women/1 man, age 20--68 yearsAsGa (laser -- Biolux, Bio-Art, São Carlos, SP, Brazil) 830 nm4 J/point500 mW20 seconds on each areaDirectly over painful area1 x per week for 4 consecutive weeksFrare et al.[@r39]^)^18Women, mean age 27 ± 7 yearsGaAs laser, 904 nm (Laserplus),6 J/cm^2^15 mW continuous16 s per pointPre-auricular region and outer acoustic meatus2x per week for 4 weeks (8 sessions)Hotta et al.[@r32]^)^109 women/1 man, mean age 35.3 years (15--67 years)GaAs Twin Laser, MM Optics, São Carlos-SP, Brazil) 780 nm.35 J/cm^2^70 mW20 sPoints employed in acupunctureOnce a week, 10 sessionsShinozaki et al.[@r33]^)^13Women, 18--36 yearsGaAs laser Bio-wave device (Kondortech) 790 nm.1.5 J/cm^2^ for TMJ, 2.5 J/cm^2^ for auriculo-temporal nerve, 3 J/cm^2^ for masseter40 mW?TMJ, region of auriculo-temporal nerve and masseterSingle sessionCarrasco et al.[@r40]^)^14?AsGaAl/Twin laser MM Optics/780 nmResulting in a dose of 105 J/cm²70 mW60 sTMJ8 sessions: 2x/week for 4 weeksTMJ temporomandibular joint. and [2](#tbl_002){ref-type="table"}Table 2.Methods, assessment tools and outcomes of randomized controlled clinical trialsAuthor/year of publicationAspect evaluatedAssessment toolsEvaluationsOutcomesPedro ScoreVenezian et al.[@r31]Pain upon palpation, masseter and temporal muscle activityRDC/TMD, VAS, EMGBefore, immediately after, and 30 days after treatmentNo differences in EMG between groups, before and after treatment. Reduction in pain in laser group for all muscles palpated, but no statistically significant difference in comparison to placebo group. Reduction in pain lasted 30 days after end of treatment in laser group with 25 J/cm², but returned after 30 days in group with 60 J/cm².6Shirani et al.[@r34]PainVASBefore and after 1 week, and 3 weeks of treatmentReduction in pain in both groups, with laser proving more effective. One patient reported return of pain 1 month after end of treatment.6Emshoff et al.[@r35]Pain during muscle functionRDC/TMD, VASBefore and after 2, 4, and 8 weeks of treatmentReduction in pain in TMJ during jaw function in both groups. No statistically significant difference between groups.7Carvalho et al.[@r36]PainVASAt the end of each of 12 sessions (comparisons only at end of treatment)64% of patients were asymptomatic or had improved after treatment. Combination of two wavelengths (red and infrared) achieved significant reduction in pain.4Salmos-Brito et al.[@r37]Pain, range of motionRDC/TMD, VAS, digital rulerBefore first session and on second day after last session (12 sessions)Significant improvements in pain intensity and maximal mouth opening after LLLT in groups with acute and chronic TMD. Greater improvements in group with acute TMD.6Da Cunha LA et al.[@r38]Pain, range of motionCraniomandibular Index, VASBefore first session and after last session (4 sessions)Significant reduction in pain in both groups after treatment according to VAS scores (p \< 0.05). No significant difference between groups regarding pain and symptoms of TMD according to craniomandibular index.7Frare et al.[@r39]PainRDC/TMD, clinical evaluation, VASBefore and after therapyStatistically significant reductions in VAS scores among sessions in treated group (p \< 0.05). Significant reduction in VAS score between first and last session only in control group (p \< 0.05).7Hotta et al.[@r32]Pain, range of motion, muscle activityMandibular range of motion, VAS, EMGBefore and after each treatment sessionStatistically significant improvements in pain and muscle activity in masseter muscles in habitual occlusion after laser applications (p \< 0.01), but no significant improvement in measures of mandibular movements (p = 0.05 + ¼).5Shinozaki et al.[@r33]Muscle activityEMGBefore, immediately after, and 5 and 20 min after treatmentReduction in EMG activity in masseter and temporal muscles in laser group. Laser therapy promoted significant relaxation of masseter muscles immediately after application.5Carrasco et al.[@r40]Pain, chewing efficiencyVAS, colorimetric method involving chewing capsuleAfter eighth application and 30 days after last applicationReduction in pain in laser group. Fewer symptoms and greater chewing efficiency after 8 sessions of laser therapy.5Marini et al.[@r41]Pain, range of motionVAS, ruler, magnetic resonanceVAS: 2, 5, 10, and 15 days after treatment. Range of motion: after 15 days and 1 month of treatment. Magnetic resonance: before and after treatmentSignificant reduction in pain in comparison to group using non-steroidal anti-inflammatory drugs. Magnetic resonance revealed disappearance of effusion in laser group. Mean measures of active and passive mouth opening and lateral excursion greater in laser group after treatment and 1 month later.5RDC/TMD: Clinical Diagnostic Criteria for Temporomandibular Disorders, VAS: visual analog scale, EMG: electromyography). Graph 1 shows the scores for each role in the PEDro scale. The scores range from 4 to 7 points.

A number of assessment tools are described in the literature for the evaluation of TMD, including questionnaires[@r23]^)^, patient history indices[@r24], [@r25]^)^, clinical indices[@r24], [@r26], [@r27]^)^, and diagnostic criteria[@r2], [@r28]^)^. Each assessment tool has advantages, disadvantages, and limitations, as well as distinct applicability. Thus, clinicians and researchers need to be aware of the data obtained using each tool in order to employ it properly. Surface electromyography (EMG) is a valuable method for the characterization and diagnosis of individuals with orofacial and occlusal abnormalities[@r29]^)^. This noninvasive tool allows the objective determination of muscle activity through electric signals with the muscle at rest or during contraction. In the investigation of TMD, surface EMG has been mainly used to evaluate the temporal and masseter muscles[@r30]^)^. Moreover, a number of reliable tools are available for the quantification of pain intensity, such as the visual analog scale (VAS), which allows the comparison of subjective pain intensity, and monitoring the effects of treatment. An algometer is another tool used in the semi-quantitative measurement of pain that allows locating trigger points and quantifying changes in different pain syndromes.

Venezian et al.[@r31]^)^ used the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD), and both the VAS and electromyography to perform evaluations prior to treatment, immediately after, and 30 days after LLLT. The authors found no significant difference in EMG activity before and after treatment. Hotta et al.[@r32]^)^ also used EMG and found statistically significant improvements (p \< 0.01) in both pain and activity of the masseter muscle in habitual occlusion following LLLT, but no significant improvement in mandibular movements using points employed in orofacial acupuncture. In contrast, Venezian et al.[@r31]^)^ used three points on the masseter and one point on the temporal muscle, and Shinozaki et al.[@r33]^)^ applied LLLT over the TMJ, region of the auriculotemporal nerve and masseter muscle in a single session. Both groups of researchers found a reduction in EMG activities of the masseter and temporal muscles.

Shirani et al.[@r34]^)^, Emshoff et al.[@r35]^)^ and Carvalho et al.[@r36]^)^ only used the VAS in the evaluation and found a reduction in pain. However, the reduction was not significant in the study by Emshoff et al.[@r35]^)^, who performed evaluations at baseline and after two, four and eight weeks covering a total of 20 treatment sessions. However, it should be pointed out that the LLLT was applied at a distance of 1 cm over the TMJ, differing from the other authors cited, who used trigger points of the masticatory muscles. Salmos-Brito et al.[@r37]^)^ also used trigger points around the TMJ, employing the RDC/TMD for diagnosis and the VAS and a digital ruler for the evaluations, which is useful for the measurement of range of motion, and found significant differences in pain intensity and maximum mouth opening after treatment.

Da Cunha et al.[@r38]^)^ employed the craniomandibular index and the VAS for evaluation and found a significant reduction in pain following treatment in both groups when using the VAS (p \< 0.05), but no significant differences in pain or symptoms of TMD when using the craniomandibular index. This index was developed by Fricton et al.[@r26]^)^ to allow the evaluation of signs and symptoms of TMD with greater precision. Frare et al.[@r39]^)^ used different evaluations in the selection of cases, comparing a clinical evaluation using a chart based on Okeson, the screening questionnaire recommended by the American Academy of Orofacial Pain, and the VAS. Carrasco et al.[@r40]^)^ employed the VAS and a colorimetric method involving the chewing of a capsule, and found that laser therapy led to a reduction in pain as well as enhanced chewing efficiency.

The LLLT application site was the treatment condition that most differed among the studies. LLLT was applied to the TMJ in five studies[@r17], [@r35], [@r37], [@r39], [@r40]^)^, the masticatory muscles in three studies[@r31], [@r34]^)^, both the TMJ and masticatory muscles in three studies[@r33], [@r36], [@r38]^)^, and the points employed in acupuncture in one study[@r32]^)^. Among the studies in which LLLT was applied to the TMJ, some papers reported positive results in comparison to a placebo group. Among the studies in which LLLT was applied to the masticatory muscles, two papers reported positive results[@r34], [@r38]^)^. However, Venezian et al.[@r31]^)^, who used three points on the masseter and one point on the temporal muscle, found a significant difference in VAS scores, but not in EMG. In a study of LLLT for both the TMJ and masticatory muscles, significant reductions were found in both pain and EMG activity after a single session[@r33]^)^. The study by Emshoff et al.[@r35]^)^, which received one of the highest PEDro scores from both assessors due to its excellent methodology, found a similar pain reduction effects in the laser therapy and placebo groups following LLLT over the TMJ, but the reduction in pain was not significant, which is in disagreement with results reported in other studies.

The number of applications differed considerably among the studies, ranging from a single application to 20 applications (2 to 3 application per week over 8 weeks). Emshoff et al.[@r35]^)^ employed the greatest number of sessions, and found a reduction in pain in the TMJ during jaw function, but there was no significant difference between the LLLT and placebo groups. Shinozaki et al.[@r33]^)^ employed a single session on the masticatory muscles and found a significant reduction in EMG activity in the masseter and temporal muscles.

The duration of each application varied from 16 seconds[@r39]^)^ to 20 seconds[@r31], [@r32], [@r38]^)^ and as much as 10 minutes[@r17], [@r34]^)^. Based on the findings of these studies, it seems that an increase in duration does not lead to enhanced effectiveness when the LLLT is applied to the TMJ. However, positive results were achieved when the LLLT was applied to the masticatory muscles for 360 seconds or more. Moreover, the findings demonstrate that while positive results were reported after a single session, no study has demonstrated how long the effects of a single session last. In a study involving eight sessions of LLLT, Venezian et al.[@r31]^)^ reported that the reduction in pain was maintained 30 days after the end of treatment.

Pain was assessed using the VAS, the number of trigger points or the craniomandibular index. Jaw function was assessed through the measure of maximum mouth opening, protrusion and lateral mandibular movements, joint sounds, chewing efficiency and muscle activity (EMG). Investigating the correlation between mandibular range of motion and pain, Salmos-Brito et al.[@r37]^)^ and Marini et al.[@r17]^)^ found improvements in both variables following treatment. Carrasco et al.[@r40]^)^ found enhanced chewing efficiency and a greater reduction in pain in comparison to a placebo group. These findings indicate that pain intensity exerts a direct influence on jaw function. Further studies are needed on the treatment of TMD, as pain is the main symptom of this disorder[@r10], [@r11], [@r15], [@r16]^)^. Moreover, muscle and/or joint impairment is prevalent among affected individuals[@r41]^)^, which can have a significant impact on quality of life and activities of daily living, such as eating, speaking, yawning and smiling[@r42]^)^.

The literature offers a wide variety of tools for the diagnosis and evaluation of TMD. The tool of choice should be based on a grounded judgment and the specific intentions of the researcher or clinician. The studies analyzed herein demonstrate the importance of a more objective evaluation involving EMG, magnetic resonance imaging, the measure of mandibular range of motion, etc., as well as other evaluations regarding the efficacy of treatment with the use of the VAS to enhance the credibility of LLLT treatment and guide clinical conduct.

DISCUSSION {#s4}
==========

As a disorder with a multifactor etiology, a number of modalities have been proposed for the treatment of signs and symptoms of TMD, such as bite plate usage, acupuncture, kinesiology, massage therapy, joint manipulation, drug therapy and LLLT[@r11], [@r15], [@r16], [@r31], [@r43]^)^. LLLT has been studied since 1905, when Albert Einstein proposed the theory of stimulated emission. In 1960, this became reality with the first emitter (ruby), developed by Theodore Maiman[@r44]^)^, and emitted a light with coherence, monochromaticity and a low degree of divergence.

According to Pinto et al.[@r45]^)^, LLLT is comprised of electromagnetic waves (either visible or invisible) of low intensity energy and wavelengths capable of penetrating tissues and influencing the synthesis, release and metabolism of numerous signaling substances involved in analgesia[@r17], [@r18]^)^. Since the publication of the first randomized clinical trial investigating the effects of LLLT on rheumatoid arthritis in the 1980s[@r46]^)^, a number of positive effects have been reported in studies involving other musculoskeletal disorders. Despite the lack of clear scientific evidence regarding the action mechanisms of LLLT[@r47], [@r48]^)^, theories have been put forth to explain the therapeutic effects capable of altering cell functions, such as reduction in bradykinin expression, edema, pain substances and inflammation time as well as increases in beta-endorphins and blood flow, the release of histamine and the promotion of muscle relaxation[@r35], [@r37]^)^.

In the interpretation of the data, discrepancies are evident in the administration parameters, number of sessions, and application sites of LLLT. A wide array of diagnostic and assessment tools for TMD is described in the literature. The choice of the most appropriate tool should be based on the specific objectives of the researcher or clinician. However, the literature offers little evidence of local and systemic analgesia following the administration of LLLT using pressure algometry as the evaluation tool[@r49]^)^.

The complexity of LLLT in the treatment of TMD and the lack of methodological quality in the clinical trials analyzed limits the indication of this physiotherapeutic modality[@r17], [@r31],[@r32],[@r33],[@r34],[@r35],[@r36],[@r37],[@r38],[@r39],[@r40]^)^. Thus, further investigations with an good study design and adequate methodology (better control of the variables and the assurance of reproducibility) are needed to identify the benefits of LLLT in the treatment of TMD.

LLLT is effective in the treatment of TMD, especially in the reduction of muscle pain. However, there is an evident lack of standardization in the parameters employed, which limits our ability to draw more definitive conclusions. The visual analog scale for pain and a clinical evaluation are the most widely used tools for the assessment of the effects of LLLT. Further studies are needed, especially randomized clinical trials, to establish the exact dose and ideal parameters for LLLT, and to define the best assessment tools in this promising field of therapy that appears to offer many benefits to individuals with signs and symptoms of TMD.
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